Skip to main content
Clinical Trials/JPRN-UMIN000022858
JPRN-UMIN000022858
Not yet recruiting
Phase 4

Investigation of satisfaction and efficacy after switching from daily DPP-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes -prospective observational study- - Study for the satisfaction and efficacy of trelagliptin

Hokkaido University Hospital0 sites48 target enrollmentJune 24, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
type 2 diabetes mellitus
Sponsor
Hokkaido University Hospital
Enrollment
48
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 24, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patient with malignant tumor 2\)Pregnancy, nursing woman or possibly pregnant woman 3\)Patients with severe infection, pre or post operation, severe trauma 4\)Patients who are taking kinds of steroid 5\)Patients with severe liver dysfunction(AST,ALT\>100U/L) 6\) Type 1 diabetes mellitus 7\) Patients with hypersensitivity to study drugs on this study 8\)Patients who can not do diet and exercise therapy 9\)Patients who thought to be inappropriate to enter this study for some reasons by physician's judgments

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Subject reported outcomes on satisfaction, efficacy and safety with Luxerm® in the field-directed treatment of thin or non-hyperkeratotic and non-pigmented Actinic Keratosis of the face or the scalpThin or non-hyperkeratotic and non-pigmented Actinic Keratosis on the face and scalpMedDRA version: 19.1Level: HLTClassification code 10020648Term: HyperkeratosesSystem Organ Class: 100000004858Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2017-000066-29-DEGalderma R&D50
Recruiting
Phase 2
Investigation of the effect of stromal vascular fraction on burn scarsBurn scars.Scar conditions and fibrosis of skinL90.5
IRCT20210515051307N1Skin and Stem cell Research Center of Tehran University10
Completed
Phase 4
Evaluation of Satisfaction and Short-term Side effect after OsteoCalVitFort Practiceside effect of Calcium vitamin D.
IRCT201312031414N30pharmedshayan pharmaceutical200
Recruiting
Not Applicable
Outcome and patients’ satisfaction after functional treatment of acute lateral ankle injuries at emergency departments versus family doctor officesateral ankle injuriesLateral ankle injuriesSurgery - Other surgery
ACTRN12608000246381niversity Hospital Bern100
Completed
Phase 4
Investigation of satisfaction, efficacy and safety after switching from daily GLP-1 receptor agonist to weekly dulaglutide in patients with type 2 diabetes -open label, randomized, parallel group controlled clinical studyType 2 diabetes
JPRN-UMIN000024552Hokkaido University Graduate School32